Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
Study results showed that patients new to antidepressant treatment and those who had restarted therapy after a lapse of 6 or more months were twice as likely to [...]

Based on its recent analysis of the cardiovascular image management systems market, Frost & Sullivan presents ProSolv CardioVascular, a FUJIFILM Company, with the 2008 North American Frost & Sullivan Award for Product Quality Leadership, in recognition of the quality of the products and services the company brings to the market.

Medtronic, Inc. (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has classified its safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems as a Class I recall. The notification relates to the improper connection of its sutureless connector intrathecal catheters (referred to [...]

Following a very successful first event in 2007, the Drug Information Association’s (DIA’s) 2nd Annual Clinical Forum: Data Driven Drug Development Decisions (October 20-23, 2008; Ljubljana, Slovenia) will focus on clinical data. New and experienced colleagues in the field of clinical and safety data management, clinical research and operations, statistics, medical information, pharmacovigilance, information [...]

Lewy body dementia is a progressive brain disease and the second leading cause of degenerative dementia in the elderly. Dementia with Lewy bodies (DLB), which is the clinical name, accounts for up to 20 percent of all dementia cases, or 800,000 patients in the United States.